09 Oct Renalyse has successfully closed an investment round of 1 M€ in public and private capital
The operation was led by the Mind the Gap program from Botín Foundation, with participation...
01 Sep Adrià Maceira, CEO Renalyse “CIMTI helps you anticipate where you will find problems”
Adrià Maceira: "We provide solutions that, through the analysis of biomarkers, warn of an imminent...
22 Apr Máshumano Foundation: Interview with the CEO
CreatSens Health was awarded last December by the Premios Jóvenes from Máshumano Foundation in the...
16 Apr CKDSens, a new device to improve the follow-up of patients with chronic kidney diseases
Solutions provided by CKDSens: ease of use of biomarker monitoring More than 90 million people in...
12 Aug ERKSens – RETOS-Colaboración 2019
The company CreatSens Health will develop a medical platform to diagnose problems in chronic kidney...
25 Jun MassMEDIC’s MedTech Virtual Accelerator Announces 2020 MedTech IGNITE Cohort
MassMedic 2020's Ignite cohort of 21 ventures—representing medtech start-ups from across the Commonwealth and beyond—are...
01 Dec CreatSens Health at 20th Barcelona Investment Forum
Biocat, in conjunction with Esade BAN, Barcelona Activa and the Barcelona Medical Association, organizes the Healthcare Barcelona Investment Forum,...
04 May Fundación Renal Íñigo Álvarez de Toledo (FRIAT) funded CreatSens project
CreatSens project from the Nanosensors group of the Universitat Rovira i Virgili has been selected as...
19 Dec EIT Health Spain awards CreatSens Health as one of the best innovation and entrepreneurship projects
EIT Health Spain awards CreatSens Health Spain celebrated its first year of activity with an...
17 Oct CaixaImpulse seleted CreatSens Health to be part of the CaixaImpulse Program
CreatSens is a project funded by the CaixaImpulse Program to monitor renal diseases at home. Creatinine...